FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tchavdar Vassilev

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Anatomy

B-Lymphocytes

Disorders

Occupations

Thermodynamics

Co-author Network

Publications

TOP 3
Iglika Djoumerska-Alexieva; Shina Pashova; Tchavdar L Vassilev; Anastas Pashov
The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response.
Jordan D Dimitrov; Anastas Pashov; Tchavdar L Vassilev
Antibody polyspecificity: what does it matter?
Sladjana Pavlovic; Nemanja Zdravkovic; Jordan D Dimitrov; Aleksandar Djukic; Nebojsa Arsenijevic; Tchavdar L Vassilev; Miodrag L Lukic
Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tchavdar Vassilev (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Iglika Djoumerska-Alexieva; Shina Pashova; Tchavdar L Vassilev; Anastas Pashov
The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response.
Autoimmunity reviews 2013;12(6):653-6.
2012: Jordan D Dimitrov; Anastas Pashov; Tchavdar L Vassilev
Antibody polyspecificity: what does it matter?
Advances in experimental medicine and biology 2012;750():213-26.
2011: Sladjana Pavlovic; Nemanja Zdravkovic; Jordan D Dimitrov; Aleksandar Djukic; Nebojsa Arsenijevic; Tchavdar L Vassilev; Miodrag L Lukic
Intravenous immunoglobulins exposed to heme (heme IVIG) are more efficient than IVIG in attenuating autoimmune diabetes.
Clinical immunology (Orlando, Fla.) 2011;138(2):162-71.
2010: Kalina A Nikolova; Nikolina M Mihaylova; Elisaveta N Voynova; Andrey I Tchorbanov; Reinhard E Voll; Tchavdar L Vassilev
Selective silencing of autoreactive B lymphocytes-Following the Nature's way.
Autoimmunity reviews 2010;9(11):775-9.
2010: Jordan D Dimitrov; Cyril Planchais; Jonghoon Kang; Anastas Pashov; Tchavdar L Vassilev; Srinivas V Kaveri; Sebastien Lacroix-Desmazes
Heterogeneous antigen recognition behavior of induced polyspecific antibodies.
Biochemical and biophysical research communications 2010;398(2):266-71.
2010: Iglika K Djoumerska-Alexieva; Jordan D Dimitrov; Elisaveta N Voynova; Sébastien Lacroix-Desmazes; Srinivas V Kaveri; Tchavdar L Vassilev
Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis.
The FEBS journal 2010;277(14):3039-50.
2009: Nikolina Mihaylova; Elisaveta N Voynova; Andrey I Tchorbanov; Pavlina Dolashka-Angelova; Jagadeesh Bayry; Bart Devreese; Srini V Kaveri; Tchavdar L Vassilev
Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Molecular immunology 2009;47(1):123-30.
2009: Jordan D Dimitrov; Tchavdar L Vassilev
Cofactor-mediated protein promiscuity.
Nature biotechnology 2009;27(10):892.
2009: Kalina A Nikolova; Andrey I Tchorbanov; Iglika K Djoumerska-Alexieva; Maria Nikolova; Tchavdar L Vassilev
Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells.
Immunology and cell biology 2009;87(7):529-33.
2009: Iglika K Djoumerska-Alexieva; Jordan D Dimitrov; Julia Nacheva; Srini V Kaveri; Tchavdar L Vassilev
Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations.
Autoimmunity 2009;42(4):365-7.
2008: Jordan D Dimitrov; Tchavdar L Vassilev; Sebastien Andre; Srini V Kaveri; Sébastien Lacroix-Desmazes
Functional variability of antibodies upon oxidative processes.
Autoimmunity reviews 2008;7(7):574-8.
2008: Jordan D Dimitrov; Sébastien Lacroix-Desmazes; Srinivas V Kaveri; Tchavdar L Vassilev
Insight into the mechanism of the acquired antibody auto-reactivity.
Autoimmunity reviews 2008;7(6):410-4.
2008: Elisaveta N Voynova; Andrey I Tchorbanov; Jozsef Prechl; Maria Nikolova; Marta Baleva; Anna Erdei; Tchavdar L Vassilev
An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes.
Immunology letters 2008;116(2):168-73.
2008: Nikolina Mihaylova; Elisaveta N Voynova; Andrey I Tchorbanov; Maria Nikolova; Antoaneta Michova; Todor Todorov; Luba Srebreva; Hristo Taskov; Tchavdar L Vassilev
Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptor.
International immunology 2008;20(2):165-75.
2008: Nikolina Mihaylova; Jordan D Dimitrov; I K Djoumerska-Alexieva; Tchavdar L Vassilev
Inflammation-induced enhancement of IgG immunoreactivity.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2008;57(1):1-3.
2007: Andrey I Tchorbanov; Elisaveta N Voynova; Nikolina Mihaylova; Todor A Todorov; Maria Nikolova; Vihra M Yomtova; Bor-Luen Chiang; Tchavdar L Vassilev
Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
European journal of immunology 2007;37(12):3587-96.
2007: Jordan D Dimitrov; Lubka T Roumenina; Virjinia R Doltchinkova; Nikolina Mihaylova; Sébastien Lacroix-Desmazes; Srini V Kaveri; Tchavdar L Vassilev
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions.
The Journal of biological chemistry 2007;282(37):26696-706.
2007: Jordan D Dimitrov; Lubka T Roumenina; Virjinia R Doltchinkova; Tchavdar L Vassilev
Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins.
Scandinavian journal of immunology 2007;65(3):230-9.
2007: Jordan D Dimitrov; Sébastien Lacroix-Desmazes; Srini V Kaveri; Tchavdar L Vassilev
Transition towards antigen-binding promiscuity of a monospecific antibody.
Molecular immunology 2007;44(8):1854-63.
2006: Tchavdar L Vassilev; Nikolina Mihaylova; Elisaveta N Voynova; M Nikolova; Michel D Kazatchkine; Srini V Kaveri
IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.
Clinical and experimental immunology 2006;145(1):108-15.
2006: Nina Ivanovska; Andrey I Tchorbanov; Jozsef Prechl; Vera Maximova; Elisaveta N Voynova; Tchavdar L Vassilev
Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
Vaccine 2006;24(11):1830-7.
2006: Jordan D Dimitrov; Nina Ivanovska; Sébastien Lacroix-Desmazes; Virjinia R Doltchinkova; Srini V Kaveri; Tchavdar L Vassilev
Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G.
The Journal of biological chemistry 2006;281(1):439-46.
2005: I Djoumerska; Andrey I Tchorbanov; Anastas Pashov; Tchavdar L Vassilev
The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used.
Scandinavian journal of immunology 2005;61(4):357-63.
2005: Iglika K Djoumerska; Andrey I Tchorbanov; Vladimira D Donkova-Petrini; Anastas Pashov; Tchavdar L Vassilev
Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.
European journal of haematology 2005;74(2):101-10.
2005: Elisaveta N Voynova; Andrey I Tchorbanov; T A Todorov; Tchavdar L Vassilev
Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes.
Lupus 2005;14(7):543-50.
2004: Andrey I Tchorbanov; Jordan D Dimitrov; Tchavdar L Vassilev
Optimization of casein-based semisynthetic medium for growing of toxigenic Corinebacterium diphtheriae in a fermenter.
Canadian journal of microbiology 2004;50(10):821-6.
2002: Jagadeesh Bayry; Anastas Pashov; Vladimira Donkova; Sandrine Delignat; Tchavdar L Vassilev; Dorothea Stahl; Blanche Bellon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Srini V Kaveri
Immunomodulation of autoimmunity by intravenous immunoglobulin through interaction with immune networks.
Vox sanguinis 2002;83 Suppl 1():49-52.
1999: Tchavdar L Vassilev; M Yamamoto; Abderrahim Aissaoui; E Bonnin; Sonia Berrih-Aknin; Michel D Kazatchkine; Srini V Kaveri
Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice.
European journal of immunology 1999;29(8):2436-42.
1999: Tchavdar L Vassilev; Michel D Kazatchkine; J P Duong Van Huyen; Médina Mekrache; E Bonnin; J C Mani; C Lecroubier; D Korinth; Dominique Baruch; Folke Schriever; Srini V Kaveri
Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg).
Blood 1999;93(11):3624-31.
1997: vincent hurez; Michel D Kazatchkine; Tchavdar L Vassilev; S Ramanathan; Anastas Pashov; B Basuyaux; Yvonne de Kozak; Blanche Bellon; Srini V Kaveri
Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease.
Blood 1997;90(10):4004-13.
1997: Srini V Kaveri; N Prasad; Tchavdar L Vassilev; vincent hurez; Anastas Pashov; Sébastien Lacroix-Desmazes; Michel D Kazatchkine
Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
Multiple sclerosis (Houndmills, Basingstoke, England) 1997;3(2):121-8.
1997: Tchavdar L Vassilev; G D Dimov; S N Marinova; A A Tchernov; A S Mikhova; Andrey I Tchorbanov; I L Bineva
An IgA, IgG and IgM-containing human immunoglobulin for oral administration to high-risk bottle-fed newborns. I. Immunochemical characterisation and antibody activity.
International journal of hematology 1997;65(3):277-83.
1996: Tchavdar L Vassilev; K V Veleva
Natural polyreactive IgA and IgM autoantibodies in human colostrum.
Scandinavian journal of immunology 1996;44(5):535-9.
1996: Srini V Kaveri; Tchavdar L Vassilev; vincent hurez; R Lengagne; C Lefranc; S Cot; P Pouletty; Denis Glotz; Michel D Kazatchkine
Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.
The Journal of clinical investigation 1996;97(3):865-9.
1995: Tchavdar L Vassilev; I L Bineva; G Dietrich; Srini V Kaveri; M D Kazatchkine
Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies.
Journal of autoimmunity 1995;8(3):405-13.
1993: Tchavdar L Vassilev; Catherine Gelin; Srini V Kaveri; Marie-Thérèse Zilber; Laurence Boumsell; Michel D Kazatchkine
Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).
Clinical and experimental immunology 1993;92(3):369-72.
1993: K Linde; B Randhagen; J Beer; V Dentchev; S Marinova; Tchavdar L Vassilev; M Bratoyeva
Shigella flexneri 2a and sonnei I vaccine with two attenuating markers: construction, tolerability and immunogenicity in 143 children aged 3-17 years.
Vaccine 1993;11(2):197-9.
1992: L G Bozadjiev; I L Bineva; Tchavdar L Vassilev
IgG subclasses distribution in immunoglobulin preparations for intravenous use.
Archivum immunologiae et therapiae experimentalis 1992;40(1):79-81.
1991: Tchavdar L Vassilev; V Valchev; G Kazarov; L Razsukanova; T Vitanov
A reference preparation for human immunoglobulin against Crimean/Congo hemorrhagic fever.
Biologicals : journal of the International Association of Biological Standardization 1991;19(1):57.
1991: V Denchev; P Nenkov; T Vitanov; T Sumerska; S Marinova; Tchavdar L Vassilev; I Panova; Momka Petrova Bratoeva; K Linde
Technological aspect of the production of live dysentery vaccines for oral administration.
Acta microbiologica Hungarica 1991;38(2):121-6.
1990: S M Vassilenko; Tchavdar L Vassilev; L G Bozadjiev; I L Bineva; G Z Kazarov
Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever.
Lancet 1990;335(8692):791-2.
1990: V Dentchev; S Marinova; Tchavdar L Vassilev; M Bratoyeva; K Linde
Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 years.
Vaccine 1990;8(1):30-4.
1990: V Denchev; T Sumerska; S Marinova; Tchavdar L Vassilev; I Panova; K Linde
Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
Acta microbiologica Hungarica 1990;37(4):359-66.
1987: Tchavdar L Vassilev; R Petrova; L Bozadjiev; Z Peeva; I Bineva
Protective activity of two human intravenous immunoglobulin preparations in experimental infection with an encapsulated Staphylococcus aureus strain.
Acta microbiologica Hungarica 1987;34(2):139-45.